Cinclus Pharma Cash Flow Reinvestment Rate
Latest as of June 2025:
0.00x
Cinclus Pharma cash flow reinvestment rate. Cinclus Pharma (CINPHA) has a Cash Flow Reinvestment Rate of 0.00x as of June 2025, reinvesting Skr295.00K (capex Skr0.00 plus investments Skr-295.00K) from operating cash flow of Skr63.94 Million. Explore CINPHA cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
Skr295.00K
Capex + Investments
Operating Cash Flow
Skr63.94 Million
SEK
Capital Expenditures
Skr0.00
SEK
Cinclus Pharma Cash Flow Reinvestment Rate by Year (None–None)
Cinclus Pharma cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Cinclus Pharma. For the full cash flow conversion analysis, see CINPHA cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow